Skip to main content
BSE
BSE Prices delayed by 5 minutes ! Prices as on   Sep 11, 2026   ABB India 7269.1 [ -0.83% ]ACC 1246.15 [ -0.70% ]Ambuja Cements 391 [ -1.26% ]Asian Paints 2470 [ -0.40% ]Axis Bank 1247.5 [ -0.99% ]Bajaj Auto 11684 [ -1.07% ]Bank of Baroda 237.8 [ -0.08% ]Bharti Airtel 1832 [ -0.27% ]Bharat Heavy 430.6 [ -0.32% ]Bharat Petroleum 304.5 [ 0.50% ]Britannia Industries 4970 [ -0.82% ]Cipla 1365 [ -1.09% ]Coal India 425.6 [ -1.82% ]Colgate Palm 1797.6 [ -0.69% ]Dabur India 376.5 [ -0.26% ]DLF 643.6 [ -1.74% ]Dr. Reddy's Lab. 1161 [ 1.77% ]GAIL (India) 173.9 [ -0.63% ]Grasim Industries 3281.55 [ -1.13% ]HCL Technologies 1207 [ 0.85% ]HDFC Bank 708 [ 2.02% ]Hero MotoCorp 5225 [ -1.04% ]Hindustan Unilever 1934 [ -0.18% ]Hindalco Industries 981.9 [ -3.64% ]ICICI Bank 1379.15 [ -0.35% ]Indian Hotels Co. 717.75 [ -0.38% ]IndusInd Bank 977.8 [ -1.73% ]Infosys 1038.2 [ 0.64% ]ITC 260.25 [ 0.48% ]Jindal Steel 1118.3 [ -2.08% ]Kotak Mahindra Bank 418.7 [ 0.42% ]L&T 3915 [ -1.01% ]Lupin 2096 [ 1.01% ]Mahi. & Mahi 3120 [ -0.94% ]Maruti Suzuki India 12410 [ -0.96% ]MTNL 24.71 [ -1.71% ]Nestle India 1384 [ -0.86% ]NIIT 92.4 [ -1.60% ]NMDC 82.45 [ -2.77% ]NTPC 333.3 [ -1.10% ]ONGC 232.55 [ -1.88% ]Punj. NationlBak 116.65 [ -0.17% ]Power Grid Corpn. 269.1 [ -1.07% ]Reliance Industries 1258 [ -1.33% ]SBI 997 [ -0.75% ]Vedanta 264.35 [ -1.78% ]Shipping Corpn. 280.2 [ -1.72% ]Sun Pharmaceutical 1842 [ -1.18% ]Tata Chemicals 612.1 [ 0.29% ]Tata Consumer 991.55 [ -0.83% ]Tata Motors Passenge 302 [ 0.50% ]Tata Steel 182.85 [ -1.67% ]Tata Power Co. 365 [ -0.54% ]Tata Consult. Serv. 2202 [ -0.65% ]Tech Mahindra 1539.5 [ 1.38% ]UltraTech Cement 10996 [ -0.52% ]United Spirits 1397.2 [ -0.12% ]Wipro 167.5 [ 0.81% ]Zee Entertainment 79.43 [ -1.93% ]

MARKETS

News Details

( As on 21/07/2026 10:25)

CDSCO approves India's first dengue vaccine

The Central Drugs Standard Control Organisation (CDSCO) has granted marketing authorisation for Qdenga®, making it India's first approved dengue vaccine for the prevention of dengue disease.

Manufactured by Takeda GmbH, Germany, and to be imported by Takeda Biopharmaceuticals India Pvt. Ltd., the vaccine is approved for individuals aged 4 to 60 years. It is administered as two subcutaneous doses, given three months apart.

The approval follows a comprehensive evaluation of the vaccine's quality, safety, and efficacy, supported by extensive global clinical trials and a pivotal Phase III study conducted in India. Qdenga® has already been approved in 42 countries, has received WHO prequalification, and over 24 million doses have been distributed worldwide.

The approval marks a significant milestone in India's fight against dengue and is expected to strengthen the country's dengue prevention strategy alongside existing vector control, surveillance, early diagnosis, and case management efforts.